Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Conte

Showing results (221-230 of 247) with videos related to

Pageof 25
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2021
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigationDaniele Belvisi, Marco Canevelli, Viola Baione, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in ItalyRiccardo Giossi, Alessandra Consonni, Valentina Torri Clerici, et al.
Journal of Neurology|January 3, 2024
Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS RegistryLorena Lorefice, Ottavia Elena Ferraro, Giuseppe Fenu, et al.
Journal of Parkinson'S Disease|October 28, 2025
The impact of diet on Parkinson's disease risk: A data-driven analysis in a large Italian case-control populationAngelo Fabio Gigante, Barbara Vitucci, Vittorio Velucci, et al.
European Journal of Neurology|May 8, 2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?Irene Schiavetti, Matilde Inglese, Jessica Frau, et al.
Epilepsia|February 14, 2007
Slow repetitive TMS for drug-resistant epilepsy: clinical and EEG findings of a placebo-controlled trialRoberto Cantello, Simone Rossi, Claudia Varrasi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 19, 2020
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factorsPietro Iaffaldano, Giuseppe Lucisano, Francesco Patti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 3, 2022
Diagnostic and therapeutic recommendations in adult dystonia: a joint document by the Italian Society of Neurology, the Italian Academy for the Study of Parkinson's Disease and Movement Disorders, and the Italian Network on Botulinum ToxinMarcello Romano, Sergio Bagnato, Maria Concetta Altavista, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2022
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapiesIrene Schiavetti, Cinzia Cordioli, Maria Laura Stromillo, et al.
Therapeutic Advances in Neurological Disorders|December 31, 2025
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian studyMatteo Lucchini, Giovanna Borriello, Shalom Haggiag, et al.
Pageof 25

Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2021
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigationDaniele Belvisi, Marco Canevelli, Viola Baione, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in ItalyRiccardo Giossi, Alessandra Consonni, Valentina Torri Clerici, et al.
Journal of Neurology|January 3, 2024
Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS RegistryLorena Lorefice, Ottavia Elena Ferraro, Giuseppe Fenu, et al.
Journal of Parkinson'S Disease|October 28, 2025
The impact of diet on Parkinson's disease risk: A data-driven analysis in a large Italian case-control populationAngelo Fabio Gigante, Barbara Vitucci, Vittorio Velucci, et al.
European Journal of Neurology|May 8, 2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?Irene Schiavetti, Matilde Inglese, Jessica Frau, et al.
Epilepsia|February 14, 2007
Slow repetitive TMS for drug-resistant epilepsy: clinical and EEG findings of a placebo-controlled trialRoberto Cantello, Simone Rossi, Claudia Varrasi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 19, 2020
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factorsPietro Iaffaldano, Giuseppe Lucisano, Francesco Patti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 3, 2022
Diagnostic and therapeutic recommendations in adult dystonia: a joint document by the Italian Society of Neurology, the Italian Academy for the Study of Parkinson's Disease and Movement Disorders, and the Italian Network on Botulinum ToxinMarcello Romano, Sergio Bagnato, Maria Concetta Altavista, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2022
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapiesIrene Schiavetti, Cinzia Cordioli, Maria Laura Stromillo, et al.
Therapeutic Advances in Neurological Disorders|December 31, 2025
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian studyMatteo Lucchini, Giovanna Borriello, Shalom Haggiag, et al.
Pageof 25